Applied Molecular Transport Long Term Debt

Applied Molecular Transport (AMTI) currently reports a long-term debt of $0 as of September 2023. That compares with $32M in the prior-year period — down 100.0% year over year. Use the charts on this page to explore Applied Molecular Transport's long-term debt history and peer comparisons.

Applied Molecular Transport's long-term debt decreased from $32M to $0 — a 100.0% year-over-year decrease (period ending September 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Applied Molecular Transport reported $0 in long-term debt as of September 2023. That compares with $32M in the prior-year period — down 100.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Applied Molecular Transport, and consider following AMTI for alerts when major investors trade the stock.

Applied Molecular Transport is classified in the Healthcare sector. On long-term debt, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing AMTI with unrelated industries.